171 related articles for article (PubMed ID: 32336069)
1. What should a cardiologist know about coronavirus disease 2019?
Sławiński G; Lewicka E
Kardiol Pol; 2020 Apr; 78(4):278-283. PubMed ID: 32336069
[TBL] [Abstract][Full Text] [Related]
2. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.
Askin L; Tanrıverdi O; Askin HS
Arq Bras Cardiol; 2020 Jun; 114(5):817-822. PubMed ID: 32491073
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus: Lessons from the COVID-19 pandemic.
Tousoulis D
Hellenic J Cardiol; 2020; 61(1):1-2. PubMed ID: 32425483
[No Abstract] [Full Text] [Related]
5. Cardiovascular disease and the impact of COVID-19.
Yoganathan A; Sajjad MS; Harky A
J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
[No Abstract] [Full Text] [Related]
6. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
Sommerstein R; Kochen MM; Messerli FH; Gräni C
J Am Heart Assoc; 2020 Apr; 9(7):e016509. PubMed ID: 32233753
[No Abstract] [Full Text] [Related]
7. Cardiovascular molecular mechanisms of disease with COVID-19.
Foo R; Wang Y; Zimmermann WH; Backs J; Wang DW
J Mol Cell Cardiol; 2020 Apr; 141():107. PubMed ID: 32289321
[No Abstract] [Full Text] [Related]
8. Cardiovascular manifestations and treatment considerations in COVID-19.
Kang Y; Chen T; Mui D; Ferrari V; Jagasia D; Scherrer-Crosbie M; Chen Y; Han Y
Heart; 2020 Aug; 106(15):1132-1141. PubMed ID: 32354800
[TBL] [Abstract][Full Text] [Related]
9. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
Diaz JH
J Travel Med; 2020 May; 27(3):. PubMed ID: 32186711
[TBL] [Abstract][Full Text] [Related]
10. Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.
Das S; K R A; Birangal SR; Nikam AN; Pandey A; Mutalik S; Joseph A
Life Sci; 2020 Oct; 258():118202. PubMed ID: 32758625
[TBL] [Abstract][Full Text] [Related]
11. COVID-19, chronic inflammatory respiratory diseases and eosinophils-Observations from reported clinical case series.
Jesenak M; Banovcin P; Diamant Z
Allergy; 2020 Jul; 75(7):1819-1822. PubMed ID: 32369190
[No Abstract] [Full Text] [Related]
12. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
[TBL] [Abstract][Full Text] [Related]
13. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
Hendren NS; Drazner MH; Bozkurt B; Cooper LT
Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: The heart of the issue.
Woodward B; Kermali M
J Card Surg; 2020 Aug; 35(8):2112. PubMed ID: 32542802
[No Abstract] [Full Text] [Related]
15. Our Response to COVID-19 as Endocrinologists and Diabetologists.
Kaiser UB; Mirmira RG; Stewart PM
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32232480
[No Abstract] [Full Text] [Related]
16. Effect of coronavirus infection on the human heart: A scoping review.
Ho JS; Tambyah PA; Ho AF; Chan MY; Sia CH
Eur J Prev Cardiol; 2020 Jul; 27(11):1136-1148. PubMed ID: 32423250
[TBL] [Abstract][Full Text] [Related]
17. Overcoming Barriers: The Endothelium As a Linchpin of Coronavirus Disease 2019 Pathogenesis?
Gustafson D; Raju S; Wu R; Ching C; Veitch S; Rathnakumar K; Boudreau E; Howe KL; Fish JE
Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1818-1829. PubMed ID: 32510978
[TBL] [Abstract][Full Text] [Related]
18. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
[TBL] [Abstract][Full Text] [Related]
19. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
Tsioufis C; Dimitriadis K; Tousoulis D
Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
[No Abstract] [Full Text] [Related]
20. COVID-19: ACE2centric Infective Disease?
Verdecchia P; Cavallini C; Spanevello A; Angeli F
Hypertension; 2020 Aug; 76(2):294-299. PubMed ID: 32476472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
